(1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate | CAS:146924-93-8

We serve (1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate CAS:146924-93-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate

Chemical Name:(1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate
CAS.NO:146924-93-8
Synonyms:(1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate
(3R,4S)-1-Benzoyl-3-acetoxy-4-phenyl-2-azetidinone
 
Physical and Chemical Properties:
Density 1.319g/cm3
Boiling Point 455.28ºC at 760 mmHg
Molecular Formula C18H15NO4
Molecular Weight 309.31600
Flash Point 229.145ºC
Vapour Pressure 0mmHg at 25°C
Index of Refraction 1.627
 
Specification:
Appearance:White to off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Paclitaxel(CAS:33069-62-4).



Contact us for information like (1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3R,4S)-1-Benzoyl-3-acetoxy-4-phenyl-2-azetidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3R,4S)-1-Benzoyl-3-acetoxy-4-phenyl-2-azetidinone Use and application,(3R,4S)-1-Benzoyl-3-acetoxy-4-phenyl-2-azetidinone technical grade,usp/ep/jp grade.


Related News: The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.3-Chloro-4-fluorobenzotrifluoride manufacturer Countries across Asia, Europe, Australia and North America have also had confirmed cases, including the UK.perfluorooctanoic acid supplier From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.DL-Homocysteinethiolactone hydrochloride vendor From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.US citizens who’ve been in other parts of mainland China in the last 14 days will undergo screening at US ports of entry and up to 14 days of self-monitoring.